Walleye Capital LLC Bausch Health Companies Inc. Call Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $169,650 - $268,450	-32,500 Reduced 34.8%	60,900 $496,000
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $556,320 - $949,392	91,200 Added 4145.45%	93,400 $650,000
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $17,094 - $23,342	2,200 New	2,200 $23,000
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $608,036 - $935,440	106,300 New	106,300 $850,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $1,827 - $2,379	300 New	300 $1,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $159,720 - $246,120	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1.6 Million - $3.74 Million	-123,500 Reduced 91.14%	12,000 $186,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $451,471 - $762,171	23,900 Added 21.42%	135,500 $4.05 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $1.37 Million - $1.68 Million	65,600 Added 142.61%	111,600 $2.44 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $235,980 - $304,175	11,500 Added 33.33%	46,000 $1.16 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $697,935 - $907,005	34,500 New	34,500 $852,000

255

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.